GSDMA and hepatocellular carcinoma: Interestingly, genetic analyses showed that the differentially expressed GSDM genes were frequently altered in HCC, predominantly by gene amplification, and patients with altered GSDM genes had a poorer OS prognosis, which might provide a theoretical basis for the tumor gene targeting therapy.